Diffusion Pharmaceuticals Earning Date (DFFN)

USA |NASDAQ |USD

DFFN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2022 Sep 2022 - - $-0.12
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2022 Sep 2022 - - $0.00

Diffusion Pharmaceuticals's next earnings date is Tuesday, Nov 8, 2022 for the fiscal quarter ending Sep 2022.

DFFN Earnings Date & History Chart

DFFN Earnings & Revenue Forecast

DFFN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-0.16 $-0.17 $-0.16

DFFN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.16 $-0.16 $-0.19

DFFN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $0.00 $0.00 $0.00

DFFN Earnings Date & Revenue History

DFFN Earnings History

|
Show More
Show More

DFFN Revenue History

|
Show More
Show More

Diffusion Pharmaceuticals Next Earnings Date & Report

DFFN Next Earnings Date & Report Preview: Sep 2022 (FQ)

DFFN's next earnings date is Tuesday, Nov 8, 2022 for the fiscal quarter ending Sep 30, 2022.

Diffusion Pharmaceuticals Previous Earnings Dates & Reports

DFFN Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Diffusion Pharmaceuticals's previous earnings date was Aug 9, 2022 for its fiscal quarter ended Jun 30, 2022.

DFFN Previous Earnings Date & Report Recap: Dec 2021 (FY)

Diffusion Pharmaceuticals's previous annual earnings date was Mar 18, 2022 for its fiscal year ended Dec 31, 2021.

DFFN's earnings per share (EPS) was $-2.22, missing the consensus analysts forecast of $-0.17 by 1205.88% , and lower than the previous year's EPS (Dec 2020) by 640.00%.

Revenues were $0.00.

The company reported a net income of $-24.10B.

Diffusion Pharmaceuticals reported a free cash flow of $-14.50M for its fiscal year, compared to $-13.55M a year ago.